Hereditary leiomyomatosis and renal cell cancer (Q92888): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Leiomiomatose hereditária e carcinoma de células renais (LHCCR) é uma síndrome de câncer hereditário autossômico dominante caracterizada por uma predisposição a leiomiomas cutâneos pilares, leiomiomas uterinos em mulheres e câncer de células renais. A condição está associada em até 16% dos casos a carcinoma de células renais agressivo. O diagnóstico é baseado tanto na presença de múltiplos leiomiomas cutâneos com pelo menos um leiomioma confirmado histologicamente quanto na presença de um único leiomioma com história familiar positiva para a doença.
description / endescription / en
 
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome characterised by a predisposition to cutaneous pilar leiomyomata, uterine leiomyomata in women and renal cell cancer. The condition is associated in up to 16% of cases with aggressive renal cell carcinoma. Diagnosis is based on either the presence of multiple cutaneous leiomyomas with at least 1 histologically confirmed leiomyoma or the presence of a single leiomyoma with a positive family history of the disease.

Revision as of 08:00, 16 August 2026

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome characterised by a predisposition to cutaneous pilar leiomyomata, uterine leiomyomata in women and renal cell cancer. The condition is associated in up to 16% of cases with aggressive renal cell carcinoma. Diagnosis is based on either the presence of multiple cutaneous leiomyomas with at least 1 histologically confirmed leiomyoma or the presence of a single leiomyoma with a positive family history of the disease.
Language Label Description Also known as
default for all languages
ID_754002573
    English
    Hereditary leiomyomatosis and renal cell cancer
    Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant hereditary cancer syndrome characterised by a predisposition to cutaneous pilar leiomyomata, uterine leiomyomata in women and renal cell cancer. The condition is associated in up to 16% of cases with aggressive renal cell carcinoma. Diagnosis is based on either the presence of multiple cutaneous leiomyomas with at least 1 histologically confirmed leiomyoma or the presence of a single leiomyoma with a positive family history of the disease.

      Statements